Matteo Puccetti
Overview
Explore the profile of Matteo Puccetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
776
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Russo M, Puccetti M, Costantini C, Giovagnoli S, Ricci M, Garaci E, et al.
Front Cardiovasc Med
. 2024 Oct;
11:1411306.
PMID: 39465131
Despite significant advances in diagnosis and treatment over recent decades, cardiovascular disease (CVD) remains one of the leading causes of morbidity and mortality in Western countries. This persistent burden is...
2.
Pariano M, Gidari A, Stincardini C, Pierucci S, Bastianelli S, Puccetti M, et al.
J Fungi (Basel)
. 2024 Jul;
10(7).
PMID: 39057395
is an environmental fungus recently included in the fungal high-priority pathogens by the World Health Organization. While immunodeficiency and/or pre-existing lung damage represent a well-recognized fertile ground for fungal growth,...
3.
Costantini C, Pariano M, Puccetti M, Giovagnoli S, Pampalone G, Dindo M, et al.
Front Mol Biosci
. 2024 May;
11:1386598.
PMID: 38721278
Humans interact with a multitude of microorganisms in various ecological relationships, ranging from commensalism to pathogenicity. The same applies to fungi, long recognized for their pathogenic roles in infection-such as...
4.
Renga G, Pariano M, DOnofrio F, Pieraccini G, Di Serio C, Villella V, et al.
Life Sci Alliance
. 2024 May;
7(7).
PMID: 38719750
Celiac disease (CD) is an autoimmune enteropathy resulting from an interaction between diet, genome, and immunity. Although many patients respond to a gluten-free diet, in a substantive number of individuals,...
5.
Zelante T, Paolicelli G, Fallarino F, Gargaro M, Vascelli G, De Zuani M, et al.
Sci Rep
. 2024 Mar;
14(1):6651.
PMID: 38509264
Multiple sclerosis is a debilitating autoimmune disease, characterized by chronic inflammation of the central nervous system. While the significance of the gut microbiome on multiple sclerosis pathogenesis is established, the...
6.
Puccetti M, Pariano M, Schoubben A, Giovagnoli S, Ricci M
Pharmacol Res
. 2024 Jan;
201:107086.
PMID: 38295917
The progress in human disease treatment can be greatly advanced through the implementation of nanomedicine. This approach involves targeted and cell-specific therapy, controlled drug release, personalized dosage forms, wearable drug...
7.
Renga G, Nunzi E, Stincardini C, Pariano M, Puccetti M, Pieraccini G, et al.
Blood
. 2024 Jan;
143(16):1628-1645.
PMID: 38227935
CPX-351, a liposomal combination of cytarabine plus daunorubicin, has been approved for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukemia (AML) or AML with myelodysplasia-related changes, because...
8.
Puccetti M, Pariano M, Schoubben A, Ricci M, Giovagnoli S
J Pharm Pharmacol
. 2023 Dec;
76(6):592-605.
PMID: 38092697
Biological membrane-engineered lipid nanoparticles (LNP) have shown enormous potential as vehicles for drug delivery due to their outstanding biomimetic properties. To make these nanoparticles more adaptable to complex biological systems,...
9.
Puccetti M, Cusati E, Antognelli C, Ricci M, Ambrogi V, Schoubben A
Polymers (Basel)
. 2023 May;
15(10).
PMID: 37242821
Biodegradable metal alloys may be successfully used to support bone repair, avoiding second surgery commonly needed when inert metal alloys are used. Combining a biodegradable metal alloy with a suitable...
10.
Czub N, Szlek J, Paclawski A, Klimonczyk K, Puccetti M, Mendyk A
Mol Pharm
. 2023 Apr;
20(5):2545-2555.
PMID: 37070956
Oral medicines represent the largest pharmaceutical market area. To achieve a therapeutic effect, a drug must penetrate the intestinal walls, the main absorption site for orally delivered active pharmaceutical ingredients...